BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11880109)

  • 1. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
    Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
    Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
    Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
    Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide.
    Scheefers-Borchel U; Müller-Berghaus G; Fuhge P; Eberle R; Heimburger N
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7091-5. PubMed ID: 2413458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
    Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
    Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latex immunoturbidimetric assay for soluble fibrin complex.
    Hamano A; Umeda M; Ueno Y; Tanaka S; Mimuro J; Sakata Y
    Clin Chem; 2005 Jan; 51(1):183-8. PubMed ID: 15514091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
    Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma levels of soluble fibrin in patients with disseminated intravascular coagulation].
    Wada H; Takeda Y; Sakakura M; Watanabe R; Nakazaki T; Shiku H; Nishioka J; Nobori T
    Rinsho Byori; 2001 Aug; 49(8):813-7. PubMed ID: 11573293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
    Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T
    Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble fibrin augments spreading of fibroblasts by providing RGD sequences of fibrinogen in soluble fibrin.
    Yang W; Wu B; Asakura S; Kohno I; Matsuda M
    Thromb Res; 2004; 114(4):293-300. PubMed ID: 15381393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
    Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
    Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin.
    Haidaris PJ; Peerschke EI; Marder VJ; Francis CW
    Blood; 1989 Nov; 74(7):2437-44. PubMed ID: 2478231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Soluble fibrin and D-dimer at normal pregnancy and pregnancy with risk of miscarriage].
    Lugovskoĭ EV; Kolesnikova IN; Lugovskaia NE; Gritsenko PG; Litvinova LM; Gogolinskaia GK; Liashko ED; Kostiuchenko EP; Golota VIa; Kurochka VV; Komisarenko SV
    Ukr Biokhim Zh (1999); 2006; 78(4):120-9. PubMed ID: 17236629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
    Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
    Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.